Athira Pharma, Inc. (ATHA) earnings
ATHA earnings moved a median of -1.33% by the close. Quarterly and annual ATHA reports and results, each read against the price at its own news timestamp. Back to the ATHA overview →
19 measured ATHA earnings events.
Where these ATHA earnings landedvs 17 measured ATHA earnings reactions
| Middle 50% of ATHA earnings reactions | -2.53% to +0.15% |
|---|---|
| Median reaction (to close) | -1.33% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 ATHA earnings events with a measured close landed between -2.53% and +0.15%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q LeonaBio, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K LeonaBio, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -1.52% | -2.53% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.52% | -2.53% | |
| Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +1.77% | +1.82% | |
| Form 10-Q Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.77% | +1.82% | |
| Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates | Press release | +0.04% | -5.92% | |
| Form 10-Q Athira Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.04% | -5.92% | |
| Form 10-K Athira Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.02% | +0.15% | |
| Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates | Press release | -4.29% | -7.71% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.29% | -7.71% | |
| Form 10-Q/A Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.99% | |
| Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates | Press release | +2.02% | -0.31% | |
| Form 10-Q Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.02% | -0.31% | |
| Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates | Press release | +0.00% | +15.81% | |
| Form 10-Q Athira Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +15.81% | |
| Form 10-K Athira Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.25% | -1.75% | |
| Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates | Press release | -5.99% | -1.33% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -5.99% | -1.33% |
Keep exploring
More ATHA: analyst actions → · SEC filings → · ATHA overview →